M. Khatib

Tocilizumab for the treatment of severe coronavirus disease 2019

A. Omrani, M. Almaslamani, M. Aboukamar, 2020, Journal of medical virology.

Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients

G. Livnat, M. Shteinberg, A. Ilivitzki, 2021, BMC Pharmacology and Toxicology.

Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report

A. Omrani, P. Coyle, Ahmed Z. I. Zaqout, 2020, Journal of medical virology.